Vivo Capital, LLC - TERNS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of TERNS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$33,489,700
-42.5%
6,657,9920.0%3.67%
-8.8%
Q2 2023$58,257,430
-26.1%
6,657,9920.0%4.02%
-26.5%
Q1 2023$78,830,625
+116207.1%
6,657,9920.0%5.47%
-29.9%
Q4 2022$67,778
-99.8%
6,657,992
+12.9%
7.80%
+103.4%
Q3 2022$34,747,000
+423.8%
5,899,372
+120.5%
3.84%
+476.0%
Q2 2022$6,634,000
-16.5%
2,675,1330.0%0.67%
+21.8%
Q1 2022$7,945,000
-58.0%
2,675,1330.0%0.55%
-52.0%
Q4 2021$18,913,000
-32.2%
2,675,1330.0%1.14%
-8.9%
Q3 2021$27,875,000
-15.0%
2,675,1330.0%1.25%
-11.8%
Q2 2021$32,797,000
-44.3%
2,675,1330.0%1.42%
-31.3%
Q1 2021$58,853,0002,675,1332.07%
Other shareholders
TERNS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 6,657,992$33,489,7003.67%
ACUTA CAPITAL PARTNERS, LLC 555,260$2,792,9581.87%
SUVRETTA CAPITAL MANAGEMENT, LLC 6,041,910$30,390,8071.64%
VR Adviser, LLC 3,092,273$15,554,1331.64%
Fairmount Funds Management LLC 2,040,000$10,261,2001.24%
Decheng Capital Management III (Cayman), LLC 714,285$3,592,8541.20%
Deep Track Capital, LP 6,000,000$30,180,0001.16%
Orbimed Advisors 7,619,135$38,324,2490.81%
SILVERARC CAPITAL MANAGEMENT, LLC 500,000$2,515,0000.76%
GREAT POINT PARTNERS LLC 645,899$3,248,8720.59%
View complete list of TERNS PHARMACEUTICALS INC shareholders